Body Composition at Discharge and Neurological Development at 2 Years in Very Preterm Infants (OPTIPREMA) (OPTIPREMA)

August 13, 2018 updated by: Jean-charles PICAUD, MD, PhD, Hôpital de la Croix-Rousse

Determinants of Body Composition at Discharge and Fat-Free Mass as an Indicator of Neurological Development at 2 Years in Very Preterm Infants : OPTIPREMA Study

This study evaluates the perinatal factors influencing body composition at discharge in very preterm infants and the relationship between fat free mass and further neurocognitive development.

Study Overview

Status

Unknown

Detailed Description

Postnatal growth is a crucial in premature infants as it could be correlated with the long-term cognitive development. Recent data from the literature show that it is possible - with appropriate nutritional care - to reduce the initial weight loss and to ensure that the growth deficit accumulated is then less important than was previously observed. The quantitative objective is to achieve growth that is at least equivalent to that of the fetus (12-18 g/kg.day according to postconceptional age). Children often grow slowly during the first 10 days of life, so they accumulate a growth deficit that should be compensated secondarily. Therefore, optimum postnatal growth is 20 g/kg.day, rather than 15 g/kg.day. It is also important to assess the quality of growth, particularly fat free mass. The objective of nutritional care is dual: a sufficient weight gain (close to fetal growth rate) but also a relevant body composition. However, there is very little data on body composition of premature babies at discharge. It is now possible to measure quickly (one minute), simply and noninvasively using pediatric air-displacement plethysmography. Previous studies using more complex search techniques to implement (dual energy X-ray absorptiometry) showed excessive body fat at discharge in premature babies. Reference values collected using pediatric air-displacement plethysmography were published in 2011. Nutritional practices and strategies have significantly evolved in the past years to support such objectives: improvement of early parenteral nutrient intake, new fortifiers for human milk, new preterm formulas and early beginning of enteral nutrition. Individualized fortification of human milk helps to provide preterm infants with sufficient amount of nutrients. The modern nutritionnal care in preterm infants results in earlier and higher protein and energy intakes than previously performed. It improves some anthropometric parameters but little is know about body composition at discharge. Furthermore, exposition to high nutrients intake could lead to metabolic and hormonal imprinting with an increased risk of diabetes and cardio-vascular diseases in adulthood.

OPTIPREMA aim to focus the link between nutrient intakes during hospitalization, body composition at discharge and relationship between fat free mass variations at discharge and neurodevelopment at 2 years.

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Preterm neonates

Description

Inclusion Criteria:

  • Preterm newborns (less or equal to 32 weeks gestation and / or birthweight less or equal to1500g).
  • Admitted in the Neonatal unit before day-of-life 7, staying at least 15 days in the unit, and discharged home at ≥ 35 weeks postconceptional age directly from the neonatal unit (no transfer)
  • Oral Parental consent

Exclusion Criteria:

  • Hemodynamic or cardiovascular instability requiring continuous monitoring or perfusion, incompatible with pediatric air-displacement plethysmography
  • Pathology inducing neurodevelopment troubles
  • Transfer in an other hospital before discharge
  • Hemodynamic or cardiovascular instability requiring continuous monitoring or perfusion, incompatible with pediatric air-displacement plethysmography

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat free mass at discharge
Time Frame: pediatric air-displacement plethysmography measurement will be done at 36 to 40 weeks postconceptional age
Fat-fee mass percentage at discharge by pediatric air-displacement plethysmography After checking inclusion and non-inclusion criteria and obtaining oral informed consent from newborn legal authority or parents, pediatric air-displacement plethysmography is performed in the last week of hospitalization. Body composition estimation is completed by clinical and demographic data collection and collection of information about neonatal nutrition.
pediatric air-displacement plethysmography measurement will be done at 36 to 40 weeks postconceptional age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors (clinical characteristics at birth and morbidity, feeding regimen) influencing body composition at discharge
Time Frame: pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Factors (nutritional and others) influencing body composition of preterm infants (<35 weeks gestation) at discharge. Analysis will focuss on condotions that could be influenced by neonatal care, such as weight gain.
pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Prediction of fat free mass at discharge
Time Frame: pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Prediction of fat free mass at discharge from anthropometric data, nutritional intakes, and evolution during hospitalization.
pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Anthropometric parameters at discharge and at 2 years
Time Frame: measurements will be done at 36 to 40 weeks postconceptional age and at 2 years of age
Relationship between anthropometric parameters and body composition at discharge and growth at 2 years
measurements will be done at 36 to 40 weeks postconceptional age and at 2 years of age
Body mass index at discharge and at 2 years
Time Frame: measurements will be done at 36 to 40 weeks postconceptional age and at 2 years of age
Relationship betwen body mass index as an marker of body composition at discharge and growth at 2 years
measurements will be done at 36 to 40 weeks postconceptional age and at 2 years of age
Fat free mass in preterm infants fed human milk fortified in an individualized way
Time Frame: pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Impact of optimized feeding regimen using adjustable individualized fortification of human milk on fat free mass at discharge
pediatric air-displacement plethysmography will be done at 36 to 40 weeks postconceptional age
Developmental score as measured by an appropriate neurodevelopmental test at 2 years
Time Frame: Neurodevelopmental assessment at 2 years old
Children neurological development at 2 years old evaluated according to the follow-up routine evaluation or very low birth weight infants
Neurodevelopmental assessment at 2 years old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

February 2, 2016

First Submitted That Met QC Criteria

February 18, 2016

First Posted (Estimate)

February 22, 2016

Study Record Updates

Last Update Posted (Actual)

August 15, 2018

Last Update Submitted That Met QC Criteria

August 13, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth of Newborn

3
Subscribe